Clinical efficacy and safety of etanercept versus sulfasalazine in patients with ankylosing spondylitis: A randomized, double-blind trial. Commentary

Tom Huizinga*, Peter Nigrovic, Eric Ruderman, Hendrik Schulze-Koops

*Corresponding author for this work

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Pages (from-to)99-100
Number of pages2
JournalInternational Journal of Advances in Rheumatology
Volume9
Issue number3
StatePublished - Dec 1 2011

ASJC Scopus subject areas

  • Rheumatology

Cite this